P5-Mouse Phenotyping

P5-小鼠表型分析

基本信息

项目摘要

This project is dedicated to the development and characterization of mouse model systems that best reflect the myelin and oligodendrocyte related (OMR) gene expression deficits in persons with schizophrenia. Several different genetically modified mouse model systems will be evaluated (e.g., Quaking, MAG, PTPRZ1, and Olig2. Each of these mouse model systems will be screened for deficits in the expression of OMR genes using a panel of OMR genes that we have shown to be differentially affected in schizophrenia. Those that evidence gene expression deficits on at least 3 OMR genes known to be affected in schizophrenia will then be assessed for behavioral deficits. The behavioral phenotyping test battery will include screening tests of simple (e.g., reflexes, locomotion, balance, sensation) as well as complex (learning, memory, startle, prepulse inhibition of startle, social interaction, anxiety) behaviors. Coupled with these purely behavioral tests will be pharmacological probes to ascertain whether pharmacological profiles commonly viewed as prototypical for rodent models of schizophrenia are also evidenced by the OMR gene deficient mice. Once "best-fit" model systems have been identified, they will be studied longitudinally to ascertain the evolution of gene expression and behavioral deficits from 3 months of age through to 18 months of age. In addition, laser capture microdissection techniques will be employed to investigate gene expression in identified cell groups. In collaboration with Project 1, the "best-fit" mouse model system will be systematically imaged by DTI in vivo at ages corresponding to those for behavioral testing. In collaboration with Project 3, brain tissue specimens from additional mice will be studied for changes in oligodendroglial proliferation, differentiation and survival. Significant progress has already been made in this regard. All of the behavioral test paradigms have been piloted and parameters have been optimized for use in mice in our phenotyping facility (results and descriptions appended). Three of the 4 animal model systems proposed for use (Quaking, Olig2, and MAG) have been obtained. Some studies have already been completed in these mice and colonies have been established to enable more large scale studies.
该项目致力于开发和表征最能反映的小鼠模型系统

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VAHRAM HAROUTUNIAN其他文献

VAHRAM HAROUTUNIAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VAHRAM HAROUTUNIAN', 18)}}的其他基金

NIH BRAIN AND TISSUE RESPOSITORY (NBTR)
美国国立卫生研究院 (NIH) 脑和组织存储库 (NBTR)
  • 批准号:
    10916989
  • 财政年份:
    2023
  • 资助金额:
    $ 23.36万
  • 项目类别:
The adaptive-innate immune interactome across multiple tissues in Alzheimer's disease
阿尔茨海默病跨多个组织的适应性先天免疫相互作用组
  • 批准号:
    10662733
  • 财政年份:
    2023
  • 资助金额:
    $ 23.36万
  • 项目类别:
Single-nucleus transcriptome profiling across multiple brain regions in Parkinson's Disease
帕金森病多个脑区的单核转录组分析
  • 批准号:
    10372330
  • 财政年份:
    2021
  • 资助金额:
    $ 23.36万
  • 项目类别:
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease
FSH 升高——阿尔茨海默病性别差异的驱动因素
  • 批准号:
    10302046
  • 财政年份:
    2021
  • 资助金额:
    $ 23.36万
  • 项目类别:
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease
FSH 升高——阿尔茨海默病性别差异的驱动因素
  • 批准号:
    10685326
  • 财政年份:
    2021
  • 资助金额:
    $ 23.36万
  • 项目类别:
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease
FSH 升高——阿尔茨海默病性别差异的驱动因素
  • 批准号:
    10495197
  • 财政年份:
    2021
  • 资助金额:
    $ 23.36万
  • 项目类别:
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease
了解人脑免疫细胞在阿尔茨海默病中的保护和神经炎症作用
  • 批准号:
    10412322
  • 财政年份:
    2020
  • 资助金额:
    $ 23.36万
  • 项目类别:
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE
本合同的目的是建立收集站点(即 NIH 大脑和组织存储库 (NBTR)),以提供积极获取、接收、处理、存储、整理、预检的服务
  • 批准号:
    10473437
  • 财政年份:
    2020
  • 资助金额:
    $ 23.36万
  • 项目类别:
THE PURPOSE OF THIS CONTRACT IS TO ESTABLISH COLLECTION SITES(S) (I.E., THE NIH BRAIN AND TISSUE REPOSITORY (NBTR)) TO PROVIDE SERVICES THAT WILL ACTIVELY ACQUIRE, RECEIVE, PROCESS, STORE, CURATE, PRE
本合同的目的是建立收集站点(即 NIH 大脑和组织存储库 (NBTR)),以提供积极获取、接收、处理、存储、整理、预检的服务
  • 批准号:
    10685914
  • 财政年份:
    2020
  • 资助金额:
    $ 23.36万
  • 项目类别:
Neuropathology Core
神经病理学核心
  • 批准号:
    10614010
  • 财政年份:
    2020
  • 资助金额:
    $ 23.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了